TerminatedNCT05521880
Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Addiction (MOUD) for Invasive Infections Related to Opioid Use
Medication studyAges 18–88United States
Understand this study
Who could participate?
Listed age limits: 18 years to 88 years.
- Listed locations
- BaltimoreSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 15, 2024
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 1
- Sponsor
- University of Maryland, Baltimore
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 88 Years
- Official registry ID
- NCT05521880
- Official title
Show the full official title
Anchoring Intermittent Long Acting Antimicrobials to Medication for Opioid Use Disorder Treatment to Facilitate Structured Transitions of Care for People Who Use Drugs Admitted to the Hospital With Invasive Infections
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Baltimore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Maryland, Baltimore, a university.
Does this study involve medication?
Yes. The study involves medication, including Oritavancin.
Who can participate?
Listed age limits: 18 years to 88 years.
Is this study still recruiting?
The registry lists this study as terminated.
